| | | GE chief Culp sells biopharma business for $21 billion | | | Shares of General Electric Co surged 11 percent on Monday after the U.S. industrial conglomerate said it would sell its biopharma business to Danaher Corp for $21 billion, its first major asset sale under new Chief Executive Officer Larry Culp. |
| |
| | | Bayer faces second trial over alleged Roundup cancer risk | | | Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court. |
| |
| | | | | | | | | | | | | | | | | | Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today | |
| | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | |
| | | » » MORE NEWSLETTERS | |
|
